Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Gyre Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $17, which forecasts a 152.98% increase in the stock price over the next year. The lowest target is $16 and the highest is $18.

Price Target: $17 (+152.98%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$17	$18	$18
Change	+138.10%	+152.98%	+167.86%	+167.86%

* Price targets were last updated on Oct 10, 2025.

Analyst Ratings

The average analyst rating for Gyre Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Roger Song Jefferies	Jefferies	Strong Buy Initiates $16	Strong Buy	Initiates	$16	+138.10%	Oct 10, 2025
Matthew Keller HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $18	Strong Buy	Initiates	$18	+167.86%	Aug 26, 2025

Financial Forecast

Revenue This Year

149.06M

Increased by 27.85%

from 116.59M

Revenue Next Year

150.25M

Increased by 0.80%

from 149.06M

EPS This Year

0.19

Increased by 746.84%

from 0.02

EPS Next Year

0.04

Decreased by -78.57%

from 0.19

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	102.29M	113.45M	105.76M	116.59M	149.06M	150.25M	451.96M
Revenue Growth	-	10.91%	-6.78%	10.24%	27.85%	0.80%	200.81%
EPS	0.03	-1.41	0.05	0.02	0.19	0.04	2.32
EPS Growth	-	-	-	-53.23%	746.84%	-78.57%	5,575.00%
Forward PE	-	-	-	-	35.29	164.71	2.90
No. Analysts	-	-	-	-	5	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	207.9M	173.0M
Avg	149.1M	150.3M
Low	112.1M	127.2M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	78.3%	16.1%
Avg	27.9%	0.8%
Low	-3.8%	-14.7%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	0.45	0.18
Avg	0.19	0.04
Low	0.02	-0.09

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	1,908.1%	-6.3%
Avg	746.8%	-78.6%
Low	-12.8%	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.